Press Releases
June 16,
2008
European Enrollment Begins in
Pivotal Phase 3 Trial of Novel Combination Medicine
Developed by Cogentus Pharmaceuticals
Download
Press Release (pdf)
May 6,
2008
New Data Show High Frequency
of Medical Claims for Gastrointestinal Events by Patients
on Antiplatelet Therapy
Download
Press Release (pdf)
Feburary
8, 2008
Cogentus Pharmaceuticals Names Scientific Steering Committee
for Global Phase 3 Clinical Program
Download
Press Release (pdf)
January
16, 2008
Cogentus Pharmaceuticals Begins Clinical Study to Confirm
the Full Antiplatelet Benefit of New Combination Medicine
CGT-2168
Download
Press Release (pdf)
January 15, 2008
Worldwide COGENT-1 Clinical Study of CGT-2168 Begins;
Focus on Reducing GI Side Effects of Antiplatelet
Download
Press Release (pdf)
December 20, 2007
Cogentus Pharmaceuticals Completes $62.5 Million Private
Financing
Download
Press Release (pdf)
November 15, 2007
Cogentus to Launch Phase III Program of Novel Combination
Product Designed to Reduce Bleeding Side Effect of Antiplatelet
Therapy
Download
Press Release (pdf) |
